NHPAP vs SBRA vs WELL vs NHI vs VTR

For growth investors, Welltower Inc.

(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). National Health Investors, Inc. (NHI) offers the better valuation at 24. 9x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, National Health Investors, Inc.

(NHI) is the cheapest at 24. 9x versus Ventas, Inc. at 161. 6x. On forward P/E, National Health Investors, Inc. is actually cheaper at 21. 0x.

Over the past 5 years, Welltower Inc.

(WELL) delivered a total return of +206. 1%, compared to +23. 5% for National Healthcare Properties, Inc. (NHPAP). Over 10 years, the gap is even starker: WELL returned +225. 2% versus NHPAP's +30. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), National Health Investors, Inc.

(NHI) is the lower-risk stock at -0. 09β versus National Healthcare Properties, Inc. 's 0. 18β — meaning NHPAP is approximately -298% more volatile than NHI relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 167% for National Healthcare Properties, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Welltower Inc.

(WELL) is pulling ahead at 35. 8% versus 2. 3% for National Healthcare Properties, Inc. (NHPAP). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -136. 5% for National Healthcare Properties, Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

National Health Investors, Inc.

(NHI) is the more profitable company, earning 37. 6% net margin versus -53. 6% for National Healthcare Properties, Inc. — meaning it keeps 37. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NHI leads at 51. 5% versus -34. 9% for NHPAP. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, National Health Investors, Inc.

(NHI) trades at 21. 0x forward P/E versus 119. 0x for Ventas, Inc. — 98. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NHI: 13. 5% to $85. 40.

All stocks in this comparison pay dividends.

Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 7%, versus 1. 3% for Welltower Inc. (WELL).

For long-horizon retirement investors, National Health Investors, Inc.

(NHI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 09), 4. 8% yield). Both have compounded well over 10 years (NHI: +59. 2%, NHPAP: +30. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: NHPAP is a small-cap quality compounder stock; SBRA is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock; NHI is a small-cap income-oriented stock; VTR is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.